These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6428718

  • 1. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B, Morel E, Bach JF.
    C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B, Bach JF, Morel E.
    Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
    [Abstract] [Full Text] [Related]

  • 3. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B, Harrison R, Lunt GG, Morris H, Savage-Marengo T, Stephenson FA.
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T, Raftery MA.
    J Supramol Struct; 1980 May; 14(3):267-79. PubMed ID: 6971372
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity of acetylcholine receptors: different forms of receptor distinguished by alpha-bungarotoxin kinetics and by antibody binding properties.
    Massa T, Mittag TW.
    J Pharmacol Exp Ther; 1983 Nov; 227(2):340-8. PubMed ID: 6631716
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B, Morel E, Bach JF.
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [Abstract] [Full Text] [Related]

  • 7. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T, Simpson JA.
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB, Appel SH.
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [Abstract] [Full Text] [Related]

  • 10. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I, Newsom-Davis J.
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M, Donnelly-Roberts D, Richman DP, Martinez-Carrion M.
    J Immunol; 1994 Jun 15; 152(12):5997-6002. PubMed ID: 8207224
    [Abstract] [Full Text] [Related]

  • 12. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor.
    Vincent A, Newsom-Davis J.
    Adv Cytopharmacol; 1979 Jun 15; 3():269-78. PubMed ID: 474297
    [No Abstract] [Full Text] [Related]

  • 13. Acetylcholine receptors and myasthenia gravis: the effect of antibodies to eel acetylcholine receptors on eel electric organ cells.
    Lindstrom J, Einarson B, Francy M.
    Prog Clin Biol Res; 1977 Jun 15; 15():119-30. PubMed ID: 928444
    [Abstract] [Full Text] [Related]

  • 14. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T, Abramsky O, Lisak RP, Zweiman B, Tarrab-Hazdai R, Fuchs S.
    Isr J Med Sci; 1978 Sep 15; 14(9):986-9. PubMed ID: 721428
    [No Abstract] [Full Text] [Related]

  • 15. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL, Ringel SP, Cook JD, Engel WK, Eldefrawi ME, McFarlin DE.
    Neurology; 1977 Dec 15; 27(12):1120-4. PubMed ID: 73154
    [Abstract] [Full Text] [Related]

  • 16. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
    Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ.
    N Engl J Med; 1978 May 18; 298(20):1116-22. PubMed ID: 643030
    [Abstract] [Full Text] [Related]

  • 17. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS, Bradley RJ, Oh SJ, Kemp GE.
    Clin Exp Immunol; 1979 Sep 18; 37(3):448-51. PubMed ID: 509779
    [Abstract] [Full Text] [Related]

  • 18. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
    Takamori M, Ishii N, Tsujihata M, Mori M, Kasai M.
    No To Shinkei; 1977 Jun 18; 29(6):597-607. PubMed ID: 334200
    [No Abstract] [Full Text] [Related]

  • 19. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H, Hayashi K, Ohta K, Itoh N, Nishitani H, Ohta M.
    Clin Chem; 1993 Oct 18; 39(10):2053-7. PubMed ID: 8403390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.